







































































The health benefits of moderate regular physical activity have been clearly demonstrated and 
are widely consensual. However, there is a growing debate over the potential adverse effects 
of strenuous physical activity, particularly at a professional level. Recent findings of 
cardiovascular anomalies in elite athletes coupled with the high frequency of injuries have 
brought some sports under increased scrutiny.  
In this context, the main goal of this work is to investigate whether elite athletes live 
longer than the general population. After an initial review of the literature on elite athletes’ 
mortality, a comprehensive survival analysis is applied to two populations of professional 
football players.  
Lifespan data and specific occupational variables of Portuguese and Spanish football 
players, who have represented their national teams in their career, were collected from 
recognized publicly available sources. Each cohort is then compared to the respective 
standard population, using available data in the Human Mortality Database, through the 
estimation of standardised mortality ratios and survival curves. The years-lost method is 
applied to provide a time dimension measure for these elite athletes’ longevity. Furthermore, 
the association of position on the field and the number of games with overall mortality is 
accessed using Cox Proportional Hazard Models. At the end, a comparison between the 
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Os benefícios para a saúde resultantes da prática regular de exercício físico, de uma forma 
moderada, estão cientificamente comprovados. Contudo, quando se trata de uma abordagem 
sobre atletas profissionais, cuja actividade física é muito intensa, os benefícios deixam de ser 
uma clara evidência, surgindo por vezes sinais de alerta para os seus possíveis efeitos 
adversos. Para alimentar esta controvérsia, muito têm contribuído os estudos recentes que 
evidenciam anomalias e doenças cardiovasculares, bem como as frequentes lesões em atletas 
de elite. 
É neste contexto que surge o principal objectivo deste trabalho: investigar se os atletas 
de elite vivem mais do que a população em geral. Após uma profunda revisão literária inicial 
relativa à mortalidade dos atletas de elite, procede-se a uma análise de sobrevivência que tem 
como foco dois grupos de jogadores de futebol profissionais. 
Recolheram-se dados relativos à data de nascimento e morte (se for o caso) dos 
jogadores portugueses e espanhóis que representaram a sua selecção, bem como de outras 
variáveis de interesse para o estudo. Cada grupo de jogadores é comparado com a população 
geral do respectivo país, usando dados disponíveis na Human Mortality Database, através da 
estimação de standardised mortality ratios e de curvas de sobrevivência. O years-lost method 
é também aplicado, fornecendo uma medida de longevidade dos referidos atletas de elite. 
Ainda é averiguado se a posição dos jogadores e o número de jogos na sua carreira afectam 
diferencialmente a mortalidade dos mesmos, através dos Cox Proportional Hazard Models. 
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Chapter 1 – Introduction 
 
Nowadays, there is little doubt that regular physical exercise is beneficial for the individuals’ 
well-being, contributing to the prevention of cardiovascular diseases, hypertension, obesity, 
depression and some types of cancer, such as colon, breast, and lung (Hurley and Reuter, 
2011). The World Health Organization (WHO, 2010) recommends that children should spend 
at least 60 minutes of moderate to vigorous-intensity physical activity daily, while adults are 
advised to do at least 150 minutes throughout the week. For additional health benefits, people 
are encouraged to increase these durations and to incorporate muscle-strengthening activities. 
 In a study about the association between the different intensities of physical exercise 
and longevity, using a cohort of 13 485 men who have enrolled as undergraduates in Harvard 
University in the period 1916-1950, the authors conclude that greater energy expenditure is 
associated with lower mortality and this trend is more pronounced for vigorous activities than 
for moderate activities (Lee and Paffenbarger, 2000).  
 However, recent controversy exists regarding the potential adverse effects of repeated 
exposure to high levels of physical exercise, such as those required at a professional sports 
level. 
One of the topics of current debate is the increased susceptibility of elite athletes to 
cardiovascular diseases. High-competitive sports may lead to physiological changes in the 
heart: the cardiac chambers enlarge and the heart muscle becomes thicker than normal, which 
is usually known as “athlete’s heart”. It has been hypothesized that prolonged aerobic exercise 
is more prone to lead to these changes; therefore, groups of ultra-endurance athletes 
(including cyclists, Ironman triathlon athletes and ultra-marathon runners) have often been 
assessed to study this relationship. These unique athletes compete in events that can last up 
to 30 hours; they usually train between 20-40 hours per week and expend over 70,000 KJ/ 
week. In addition, it should be noted that the number of individuals participating in these 
events is continually increasing as evidenced by the number of new races established each 
year.  
The results of the studies are somewhat conflicting. Some authors reach the 
conclusion that ultra-endurance exercise elevates oxidative stress, leading to the development 
of acute cardiac dysfunction as evidenced by electrocardiography abnormalities, myocardial 
injury or atherosclerosis, consequently increasing the risk of cardiovascular diseases and 
mortality (Knez, Coombes and Jenkins, 2006; Laslett, Eisenbud and Lind, 1996). La Gerche 





affects the right ventricular, which correlates with increases in biomarkers of myocardial 
injury and it is more prevalent in athletes with a longer history of competitive sport. In 
contrast, other studies do not find measurable persistent abnormalities of cardiac function in 
ultra-endurance elite athletes, suggesting that the response to oxidative stress might be 
mitigated as a result of exercise-induced adaptations, such as increased antioxidant defense 
and less reactive oxygen species production (La Gerche et al., 2004).  
In a comprehensive study assessing world-class endurance athletes (Pelliccia et al., 
2010), no cardiovascular events occurred and uninterrupted training/competition over long 
periods of time (for more than eight years on average) was not associated with deterioration 
in left ventricular function, significant changes in left ventricular morphology or onset of 
symptoms of cardiomyopathies.   
 The debate on the consequences of heart remodeling in elite athletes and the safety of 
long-term and intense sports participation is fueled by news media reports of sudden cardiac 
deaths. The most shocking case in Portugal was the death of the professional football player 
Miklós Fehér at age 24, during a match (2004). The cause of death was cardiac arrhythmia, 
brought on by hypertrophic cardiomyopathy, which is known as a leading cause for cardiac 
arrests in young athletes and it usually asymptomatic. 
 Along with the premature deaths, the high frequency of injuries has brought some 
sports under increased scrutiny, especially those with a high risk of bodily collision and high 
physical contact. For instance, chronic traumatic encephalopathy is a progressive 
degenerative disease, most commonly found in elite athletes participating in American 
football, boxing, ice hockey and rugby, with a history of repetitive brain injuries, including 
symptomatic concussions (Koning et al., 2014; McKee et al., 2009; Zwiers et al., 2012). This 
disease leads to early onset dementia and it is associated with reduced life expectancy.  
 A number of studies have thus attempted to study the risk-benefit ratio of intensive 
exercise by assessing mortality in elite athletes. The scientific literature, which is reviewed 
in Chapter 2, provides a major evidence of lower mortality in elite athletes, as well as a higher 
life expectancy. 
 Following the brief introduction and the literature review, Chapter 3 introduces the 
main methods used to assess mortality of a population, with particular evidence given to its 
comparison to a standard population.  
 The main findings in the literature on elite athletes’ mortality vary according to 





in sports or the follow-up time provide large variations in the results. Consequently, estimates 
from these studies are not easily transposable to other elite populations.  
An exhaustive research on this topic was performed and, to date, it was not found any 
study on the mortality/longevity of Portuguese athletes, whether among professional or 
amateurs, male or female. Given the interest in this population, the next step of this work 
involved the collection and creation of the data set, which revealed to be one of the most time-
consuming tasks. It has implied contacting and visiting the Portuguese Federations of several 
sports, the Portuguese Institute of Sports and Youth (Instituto Português do Desporto e 
Juventude) and the office of the insurance company Fidelidade (which works with sports and 
health insurance of high performance athletes). At the end, internet has showed to be the best 
source of data. The only successful group of Portuguese elite athletes for whom it was 
possible to create a data set was the football players, in particular, those who have already 
represented the National Team. In order to have a broader study, data on Spanish football 
team players was also collected, resulting in an Iberian analysis. 
The process of data collection, the statistical analysis and the results obtained are 
presented in Chapter 4, the main contribution of this paper. Regarding the software employed 
in this work, Excel was used for data set building and making simple analyses; R was the 
chosen tool to compute mortality measures and to develop regression models.  
 Finally, Chapter 5 includes the relevant conclusions, limitations of the study and 



















Chapter 2 – Literature Review 
  
A majority of studies assessing elite athletes’ mortality and longevity shows that elite athletes 
survive longer than the general population, with these differences being more pronounced for 
endurance and mixed-sport athletes.   
 In two different studies of cyclists who have participated in the Tour de France, it was 
reported a substantially and significantly lower mortality in cyclists, compared to the general 
male population (Marijon et al., 2013; Sanchis-Gomar et al., 2011). These professional 
cyclists constitute one population of particular interest, since Tour de France is one of the 
most demanding and difficult sports event in the world, during which cyclists cover around 
3500km in three weeks. 
 Sanchis-Gomar et al. (2011) consider the participants in the Tour de France between 
the years 1930 and 1964, excluding cyclists for whom they do not have proof of date of birth 
or death, who did not complete all stages and who were born in countries that have contributed 
with less than 100 participants during this period. The final sample consists of 834 cyclists, 
from France (n=465), Italy (n=196) and Belgium (n=173). Portuguese cyclists are not 
included, since they only represented 0.24% of the total number of participants. The authors 
compute the “percentage of survivors” for each age, given by the number of cyclists born in 
a given year who were alive on 31 December 2007, divided by the number of cyclists born in 
that given year. This survival rates are compared with those of the pooled general population 
of France, Italy and Belgium, for the appropriate birth cohorts (men born between 1892 and 
1942, the years in which the cyclists studied were born). A polynomial regression curve of 
second order (Ribeiro, 2014; Wooldridge, 2012), in the age–survival (%) axis, is adjusted for 
each population and a non-parametric Mann-Whitney U test (Mann and Whitney, 1947) is 
applied for comparing the mean of the percent survival. The curve of the cyclists lies above 
the curve of the general population for all ages and by comparing the areas under the curves, 
the authors reach the conclusion that longevity of the cyclists is significantly higher (p<0.05). 
The estimated average of survival between 65 and 115 years is 39.1% in cyclists, while for 
the general population it is 21.5%. The authors also compare the age at which 50% of the 
population dies:  73.5 years for the general population vs. 81.5 years in the Tour de France 
participants. 
 In the study including only the French cyclists participating at least once in Tour de 
France from 1947 to 2012 (Marijon et al., 2013), the reduced mortality was confirmed with 





categories, calendar periods and specific causes of death, besides the overall ratio. A measure 
of longevity was also used, namely, the additional life span of cyclists who participated in the 
Tour between 1947 and 1951, which is estimated by 6.3 years compared to the reference 
population. 
 Lin, Gajewski, and Poznańska (2016) applied a parametric frailty survival model to a 
group of Polish athletes who have participated in the Olympic Games from 1924 to 2010. The 
study was restricted to the athletes born between 1890 and 1959, after concerns about medical 
improvements and the statistical power for parametric survival analysis. The authors fitted a 
ϒ-Gompertz hazard function to account for possible unobserved heterogeneity (ϒ; variance), 
which can arise from different region of birth, energy expenditure, nutrition and so on. The 
hazard function is given by 𝜇(𝑥) = 𝑎. 𝑒𝑏𝑥, therefore, the parameter b measures the rate of 
ageing and a represents the magnitude of the hazard. The athletes were preassigned to two 
birth cohorts, 1890-1919 (cohort I) and 1920-1959 (cohort II), in order to account for 
socioeconomic changes and medical advancements. Results from cohort I suggest that Polish 
elite athletes exhibit lower risk of mortality and a slower rate of ageing (boly=0.08616) than 
the general population from the same birth cohort (bhmd=0.09762). Regarding cohort II, 
mortality risk is also lower for athletes than for the general population, however, the estimated 
rate of ageing is similar (boly=0.08467 and bhmd=0.08327). This last result may be attributed 
to mortality improvements in Poland from year 1920 onwards. Actually, athletes benefited 
from a 50% reduction in mortality from cohort I to cohort II and the estimated overall 
mortality risk of the Polish general population is 29% lower in Cohort II than in I.  
 Sarna et al. (1993) estimated that Finnish long-distance runners and cross-country 
skiers, competing internationally between 1920 and 1965, live 5.7 years longer than age and 
area of residence-matched reference male cohorts in Finland.  
 Regarding team sports athletes, for example, baseball players (Abel and Kruger, 
2005; Kalist and Peng, 2007) and National Football League (NFL) players (Koning et al., 
2014) show lower mortality rates than general population.  
 There are many possible explanations for this apparent survival advantage of elite 
athletes. High physical fitness levels, achieved by daily vigorous exercise, are one of the 
crucial beneficial factors. Such excellence in sport is attained only by the healthiest and the 
fittest individuals, which may be partially explained by genetic predisposing factors; 
therefore, professional athletes are usually regarded as a select group. Moreover, elite athletes 
have a better access to quality health care, due to their medical team support and higher 





alcohol than the general population. Finally, elite athletes, especially endurance ones, tend to 
maintain these healthy lifestyle habits and remain active after retirement.  
 However, a few studies do not find a survival benefit of elite athletes. For example, 
Italian soccer players active in the three top leagues, between 1960 and 1996, do not show a 
mortality difference from the Italian population (Belli and Vanacore, 2005). Likewise, New 
Zealand rugby players had the same life expectancy as the general population (Beaglehole 
and Stewart, 1983). 
Furthermore, there is a report by Pärssinen et al. (2000) observing that 12.9% of 
Finnish powerlifters died prematurely (mean age of death=43 years) compared to 3.1% of the 
general population during a 12-year follow-up period. The use of anabolic steroids to enhance 
performance and the higher prevalence of obesity and diabetes later in life are reasons 
proposed for the higher mortality of powerlifter athletes. 
 In some cases, an excess mortality by specific causes of death is observed for elite 
athletes, in comparison with standard population.  
 Two distinct studies conclude that Italian soccer players have considerably high death 
rates for diseases of the nervous system, mainly from amyotrophic lateral sclerosis (ALS). 
Belli and Vanacore (2005) reached a standardised proportionate mortality ratio for ALS of 
11.58, when analysing Italian soccer players active in the period 1960-1996. Taioli (2007) 
studied a cohort of soccer players who were enrolled in the Italian A and B professional 
leagues for at least one season, between 1975 and 2003, recording a standardised mortality 
ratio for ALS of 18.18, without significant variation across calendar year. 
 Although the overall mortality was significantly reduced in the cohort of 3439 NFL 
players, with at least 5 pension-credited playing seasons from 1959 to 1988 (SMR=0.53), 
neurodegenerative mortality was estimated to be three times greater than that of the general 
US population, possibly related to the higher chronic traumatic encephalopathy (Lehman et 
al., 2012). 
 In contrast to the studies presented before, where elite athletes are compared to the 
general population, in one article by Zwiers et al. (2012), the comparison is made among the 
Olympic athletes practicing sports with different levels of physical intensity and contact. The 
study assesses the mortality risk of 9889 athletes who participated in the Olympic Games 
between 1896 and 1936 in 43 different disciplines, which are classified in categories of: static 
intensity, dynamic intensity, cardiovascular intensity, physical contact and bodily collision. 
The authors calculate hazard ratios for all-cause mortality by using a left truncated Cox 





disciplines with increasing cardiovascular intensity are not associated with a significantly 
higher mortality risk. A separate analysis of the static and dynamic components shows similar 
non-significant results. These conclusions do not change under a multivariate analysis. The 
study points a higher mortality for those practicing sports with a high risk of bodily collision 
and high physical contact (hazard ratios of 1.11 and 1.16, respectively). A note for the fact 
that bodily collision becomes non-significant in a multivariate analysis, as a consequence of 
its close relation with physical contact. Identical analysis is developed for subgroups – men 
only, deaths after age 50, born before/after 1900 – and the results are similar to the mentioned 
above.  
 Other works show that mortality results vary even for athletes practicing the same 
sport. For instance, in the study including NFL players from two different seasons (Koning 
et al., 2014), besides the analysis of overall mortality, the players are divided in subgroups, 
by race, position played (line, skill and other) and number of games during their career. A 
Cox Proportional Hazard Model is developed to examine if the observable risk factors 
mentioned above influence mortality within the population of NFL players. There is evidence 
that line players have higher mortality than other players, which is expected since they are 
more susceptible to some kind of diseases (e.g.: cardiovascular diseases due to their higher 
body mass index (BMI)).  In the 1970 cohort, white players exhibit a 33% lower hazard rate 
than non-white players, but this difference is no longer valid for the 1994 cohort. An 
interesting finding is that players who play more than two seasons worth of games face higher 
mortality rates than other players, registering a 347% higher hazard rate. In another study 
using a different cohort of NFL players, Baron et al. (2012) evaluated the association of 
position category and BMI with cardiovascular disease mortality. The BMI was treated as a 
categorical variable, with three levels: normal (18.5 to <25 kg/m2), overweight (≥25 to 30 
kg/m2) and obese (≥30 kg/m2). Among other results, the authors found that CVD mortality 
was increased for players with BMI≥30kg/m2 in comparison to normal BMI (HR: 2.02; 95% 
CI: 1.06 – 3.85) and for defensive linemen compared to offensive linemen (HR: 2.07; 95% 












Chapter 3 – Methods to quantify and compare 
mortality 
 
This chapter introduces the methodologies used to quantify and compare the mortality 
experience of different populations, and to monitor the progress over time of the populations’ 
mortality. In this analysis, there is a special focus on comparing the mortality of the 
population under study (specific cohort of elite athletes) with a standard population 
(reference/general population).  
 
3.1 Measures of comparative mortality  
 
One of the possible approaches involves the computation of summary (single figure) 
mortality indices. The general notation and definitions will be presented, having as main 
references the Core Reading - Subject CT5 in IFOA (2011), and Breslow and Day (1987). 
 In the context of comparing the mortality results of different populations, a problem 
arises if they have different structures with respect to background characteristics.  One 
example is comparing mortality figures of populations (for example, Portuguese cyclists and 
Portuguese football players) with different age distributions. In this case, rates and ratios must 
be adjusted to ensure the comparability between the heterogeneous populations, a process 
known as standardisation, which has been used in actuarial applications since the mid-18th 
century (Keiding, 1987). Besides the example of age, mortality rates are commonly 
standardised by sex, race and calendar period. Other factors such as occupation, nutrition, 
housing, education and genetics, also contribute to differences in mortality (distorting 
variables); nevertheless, extensive data may be required so these adjustments are less 
frequently applied. Each population is said to be decomposed in groups (strata), having 
certain characteristics in common. Throughout this study, mortality rates are standardised by 
sex, age and calendar period. For example, one possible stratum could be: men, aged 30-35, 
during calendar period 1950-1955. 
 Mortality rates can be calculated either for total deaths or for separate causes of 
interest. However, only overall mortality rates are computed here, since it was not possible 







3.1.1 General notation 
Considering that the population being studied is divided in 𝑀 classes (groups, strata), the 
following notation will be used for the cohort:   
• 𝐸𝑗: central exposed to risk in class 𝑗 (𝑗 = 1,… ,𝑀) 
• 𝑑𝑗: number of deaths in class 𝑗 (𝑗 = 1,… ,𝑀) 
• 𝑚𝑗: central rate of mortality in class 𝑗 (𝑗 = 1,… ,𝑀) 
The notation is modified by the addition of the superscript “𝑠” when it refers to the 
standard population, instead of the population under study. For example, 𝐸𝑆 𝑗 is the central 
exposed to risk in class 𝑗 in the standard population.  
 The central rate of mortality is preferentially used in population studies, in opposition 
to the initial rate of mortality (probability of death), 𝑞𝑥. This last one is obtained dividing the 
number of deaths, 𝑑𝑥, by the number of individuals alive at age 𝑥, 𝑙𝑥. Intrinsically, it is 
assumed that 𝑙𝑥 individuals are alive between ages 𝑥 and 𝑥 + 1, which is an inconvenient, 
since people who die during that year of age will not be exposed to risk during the whole 
year. As an alternative measure, 𝑚𝑥 is computed dividing 𝑑𝑥 by the expected number of 
individuals living between ages 𝑥 and 𝑥 + 1 (exposure-to-risk), given by ∫ 𝑙𝑥+𝑡
1
0
𝑑𝑡. So, while 
𝑞𝑥 is the probability of an individual now aged 𝑥 dying within the next year, 𝑚𝑥 is the 
probability of a life aged anywhere between 𝑥 and 𝑥 + 1 dying before attaining age 𝑥 + 1. 
  
3.1.2 Computation of central exposed to risk 
The central exposed to risk for an individual in the 𝑗-th group is the period of time during 
which the individual is followed-up in that group, from his/her entry until his/her exit. 𝐸𝑗 is 
obtained by summing up the contributions of all individuals in the same stratum 𝑗. The total 
exposed to risk, also known as population at risk or exposure-to-risk, is determined by 
adding up the values of the central exposed to risk of all categories, from 𝑗 = 1 to 𝑗 = 𝑀. The 
mortality rates are often expressed in terms of annual rates (i.e., per year) and in this case the 
exposed to risk is called “person-years” of observation. 
 As a first approach, exposure-to-risk will be determined considering only 
standardisation by age. In this case, 𝐸𝑥,𝑡 is used to denote the central exposed to risk in the 





In cohort studies during a long period of time there are inevitably withdrawals of 
individuals (due to death, inability to trace…) and often new individuals are added to the 
cohort.  
 Defining: 
• Date A = max (date of reaching age 𝑥, start of the investigation, date of entry) 
• Date B = min (date of reaching age 𝑥 +  𝑡, end of investigation, date of exit) 
  
 The evaluation of central exposed to risk becomes more difficult when stratification 
is performed with respect to other variables besides age. As already mentioned, the 
standardisation of individual follow-up time in this study is performed by age, calendar period 
and sex. First, for each individual, it is determined the amount of observation time contributed 
to each category, defined by a combination of the three variables. Subsequently, the observed 
times of all cohort members are summed up to obtain the population at risk in that same 
category.  
 For the population of football players, which is composed only of men, the categories 
are defined by a given age-band and a certain calendar period.  The calendar scale as well as 
the age scale are often divided in one, five or ten-year intervals, in order to make the published 
national death rates directly applicable in the computation of the expected number of deaths.  
 As a simple illustration, consider a player, who was born on 15 February 1980, enters 
the study on 5 April 2002 and leaves the study on 14 June 2005. Therefore, he starts to be 
followed with 22.13 years (point A) and his age at exit will be 25.33 years (point B). 
Considering age-class and calendar period of one year, he contributes with observation times 
to seven different categories, as shown in Figure 3.1.   
 The exposed to risk of each category equals the corresponding width of the lattice at 
the bottom. Since the two variables in the axes have the same scale, only four different values 
of exposed to risk need to be calculated, namely, the first and the last widths of the lattices 
(in the example, 1 and 7, respectively); the value of the lattices with even numbers and the 
value of the lattices with odd numbers.  
Define 𝑊𝐼𝐷𝑇𝐻 as the width of each variable in the axis and consider 𝑎𝑢𝑥1, 𝑎𝑢𝑥2, 











    
    
    




Figure 3.1 – Lexis diagram divided into 1x1 cells (one year of age by one year of time) to illustrate the 
follow-up of a hypothetic individual and the computation of his exposure to risk. 
 
 The property of the sum of neighbor widths being equal to the scale of the original 
variables (𝑊𝐼𝐷𝑇𝐻), unless one of them is the first or the last lattice, allows determining the 
population at risk: 
 𝑤𝑖𝑑𝑡ℎ1 =  𝑚𝑖𝑛 {𝑎𝑢𝑥1, 𝑎𝑢𝑥2} 
 𝑤𝑖𝑑𝑡ℎ2 = |𝑎𝑢𝑥1 − 𝑎𝑢𝑥2|(= 𝑤𝑖𝑑𝑡ℎ4 = 𝑤𝑖𝑑𝑡ℎ6) 
 𝑤𝑖𝑑𝑡ℎ3 = 𝑊𝐼𝐷𝑇𝐻–𝑤𝑖𝑑𝑡ℎ2(= 𝑤𝑖𝑑𝑡ℎ5) 
 𝑤𝑖𝑑𝑡ℎ7 =  𝑚𝑖𝑛 {𝑎𝑢𝑥3, 𝑎𝑢𝑥4}  
 
 The individual contribution to the exposed to risk by this athlete is summarised in 
Table 3.1, where values are in days. Notice that the output obtained when using software may 
be different, since some adjustments are usually performed to consider leap years and 





2002 2003 2004 2005 
22 271 45   
23  320 45  
24   320 45 
25    120 
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 The computation of exposed to risk is crucial for evaluating the following mortality 
measures. 
 
3.1.3 Crude Mortality Rate (CMR) 
The crude (non-standardised) mortality rate for a particular population is the total number of 
deaths observed during the period divided by the total exposed to risk for the same period.  
 
𝐶𝑟𝑢𝑑𝑒 𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦 𝑟𝑎𝑡𝑒 =  








This rate can be calculated just for a certain category, for example, as the ratio of total 
number of deaths in one age-class to the total exposed to risk in the same age-class. 
Comparing crude mortality rates of different populations might give a misleading 
result, since the measure does not take into account differences in their demographic 
structures. In particular, the crude mortality rate disregards the age structure of the population.  
If one population is, on average, younger than the other, then, even if the age-specific rates 
were the same in both populations, more deaths would occur in the older population than in 
the younger, considering exactly the same period of observation. Actually, given higher crude 
mortality rates in a population X at each age-class than in a population Y, it is possible to 
obtain a lower overall crude mortality for population X, as illustrated in the example below. 
 








20 75 000 225 0.003 10 000 20 0.002 
40 15 000 75 0.005 15 000 60 0.004 
60 10 000 100 0.010 75 000 525 0.007 
Total 100 000 400  100 000 605  
 CMRX = 0.004  CMRY = 0.00605  
Table 3.2 – Example of computation of CMR to illustrate that this measure can be misleading if used to 
compare the two populations. Adapted from: IFOA (2011), Core Reading: Subject CT5, Chapter 15. 
  
A valid comparison is obtained when the mortality rate is recomputed by assuming 
the same age structure in the two populations, which is one form of standardisation, as already 
mentioned.   
 There are two types of standardisation, direct and indirect, both requiring assumption 






3.1.4 Directly Standardised Mortality Rate (DSMR) 
The directly standardised mortality rate is obtained by applying the stratum-specific cohort 












 This measure can be regarded as a weighted average of the stratum-specific cohort 
mortality rates, with the weights being the stratum-specific proportions in the standard 
population, 𝑤𝑗





 :                                                                                               (3) 
 





If the standardisation is only by age, the directly standardised mortality rate is the 
number of deaths that would have occurred in the standard population if it had the age-specific 
mortality of the cohort, divided by the total central exposed to risk of the standard population. 
Provided that the same reference population is used in the standardisation, computation of 
directly standardised rates is expected to provide a meaningful comparison between the 
mortality experience of different cohorts, by eliminating the effect of different age structures. 
However, the standard population affects this measure, so it should be chosen carefully.  
 
3.1.5 Indirectly Standardised Mortality Rate (ISMR) 
The indirectly standardised mortality rate is defined as the crude mortality rate for the 
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 The rate can also be decomposed as:  
𝐼𝑆𝑀𝑅 = 𝐹 x CMR for population under study , 















𝐶𝑟𝑢𝑑𝑒 𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦 𝑟𝑎𝑡𝑒 𝑓𝑜𝑟 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑝𝑜𝑝𝑢𝑙𝑎𝑡𝑖𝑜𝑛
𝐶𝑟𝑢𝑑𝑒 𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦 𝑟𝑎𝑡𝑒 𝑓𝑜𝑟 𝑐𝑜ℎ𝑜𝑟𝑡,   𝑢𝑠𝑖𝑛𝑔 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑚𝑜𝑟𝑡𝑎𝑙𝑖𝑡𝑦
                (6) 
is the Area Comparability Factor. A value of 𝐹 greater than 1 indicates that the structure of 
the population being studied is more heavily weighted towards individuals who experience 





 Usually, the indirectly standardised mortality rate gives a good approximation to the 
directly standardised mortality rate and it is often more easily calculated, since it is not 
necessary to know the stratum-specific mortality rates of the cohort (only the total number of 
deaths).  
 It is possible to take important conclusions from the last single figure indices: 
- If the DSMR, the ISMR and the crude mortality rate for the standard population are greater 
than the crude mortality rate for the studied population, then, the reason for the lower 
mortality rate of the cohort is its population distribution (by the variables being used in the 
standardisation); 
- If the crude rate for the standard population is greater than both the DSMR and ISMR, the 
crude rate for the studied population is lower, even allowing for the population distribution. 
 
3.1.6 Standardised Mortality Ratio (SMR) 
The standardised mortality ratio has been one of the most used summary mortality measures. 
The SMR compares the observed number of deaths in the population being studied with the 
expected number of deaths obtained by applying the stratum-specific mortality rates of the 
standard population to the corresponding population at risk in the cohort.  

















𝑎𝑐𝑡𝑢𝑎𝑙 𝑑𝑒𝑎𝑡ℎ𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑐𝑜ℎ𝑜𝑟𝑡
𝑒𝑥𝑝𝑒𝑐𝑡𝑒𝑑 𝑑𝑒𝑎𝑡ℎ𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑐𝑜ℎ𝑜𝑟𝑡
 (7) 
 
 Notice that the indirectly standardised mortality rate is obtained multiplying the crude 
mortality rate of the standard population by the SMR. 
 One advantage of the SMR is that stratum-specific numbers of deaths (or stratum-
specific mortality rates) in the cohort are not required for its calculation, only the total number 
of deaths. This allows application of the SMR to published data which omits details on the 
number of deaths by subgroup but gives information about the population at risk. 
 A value of the SMR lower than 1 indicates that the study population exhibits lower 
mortality than the standard population, and vice-versa. 
Besides estimating the SMR, one question of interest is its statistical significance. The 
hypothesis test and the determination of confidence intervals are explained in the Appendix. 
 This summary statistic is widely used in studies on mortality and longevity of elite 
athletes, engaging in different types of sports: 
 - An overall SMR of 0.59 shows a substantially and significantly lower mortality in 





(Marijon et al., 2013). Cyclists are also grouped in the intervals 1947-70, 1971-90 and 1991-
2010, according to their participation in Tour de France. The reason behind this is to address 
(indirectly) the possible effect of doping on long-term mortality and to account for mortality 
trends. For the first two periods, it is observed a 41% and 32% lower mortality in French 
cyclists, while no deaths are recorded in the last period. It is also taken into account a possible 
age period interaction, again resulting in SMR lower than 1, without any significant 
difference over time. Reduction in mortality is also verified for major causes of death, which 
are neoplasms (SMR: 0.56) and cardiovascular diseases (SMR: 0.67). The exception is 
mortality associated to external causes (mainly, trauma-related), with no clear difference 
between cyclists and the general population. 
 - Taioli (2007) concluded that the SMR of the cohort of professional soccer players 
enrolled in Italian A and B leagues from 1975 to 2003 is 0.68, based on age and calendar-
period stratified mortality from the general male population in Italy. However, a significantly 
higher than expected number of deaths for ALS and car accidents was observed, giving SMR 
of 18.18 and 2.23, respectively. 
 - The mortality experience of Major US league baseball players is found to be lower 
than that of the reference population in several studies. For example, Kalist and Peng (2007) 
observe an actual number of deaths 69% lower than the expected (SMR=0.31), for players 
born between 1945 and 1964; Reynolds and Day (2012) compute a SMR which is higher but 
still significantly lower than 1 (SMR=0.87) for the 1930-1999 period. 
 - In another study including the Polish athletes participating in the twentieth century 
Olympics since 1924, the SMR is 0.5 for males and 0.73 for females, using as standard 
population the urban Polish males, and females, respectively, also stratifying by age 
(Gajewski and Poznańska, 2008). 
 - Danish athletic champions, record-holders and members of national teams from 19 
different sports, born in the calendar-period 1880-1910, are divided in three age-classes in a 
study conducted by Schnohr (1971). The male elite athletes had a significantly lower 
mortality than the standard population under the age of 50 years (SMR=0.61 in the life period 
25-49 years), while the actual deaths were not significantly different from the expected deaths 
after 50 years old (SMR=1.08 in 50-64 years and SMR=1.02 in 65-80 years). 
 The standardised mortality ratio is also used to evaluate morbidity rates, being known 
in this context as standardised incidence ratio (SIR), a summary statistic that assesses the risk 
associated with a specific disease. The SMR and SIR are particularly applicable when the 
population under study is so small, or the event of interest is rare, that the resulting stratum-





3.2 Observed and expected survival function  
 
Besides providing single summary measures of mortality, it is useful to compare two (or 
more) populations based on the estimation of their survival functions. 
The survival function is defined as 𝑆(𝑡) = 𝑃(𝑇 > 𝑡) = 𝑝0𝑡  and represents the 
probability that an individual at time or age 0 survives at least 𝑡 years. On the other side, the 
lifetime distribution function from time or age 0 is defined as 𝐹(𝑡) = 1 − 𝑆(𝑡) = 𝑃(𝑇 ≤ 𝑡) =
𝑞0𝑡 , and represents the probability that the individual does not survive beyond time or age 𝑡. 
 
3.2.1 Kaplan-Meier method – Estimation of observed survival 
The Kaplan-Meier estimator of the survival function is one of the most widely used methods 
for statistical comparison and graphic display of survivorship over time, not requiring a 
functional form for the survival function (non-parametric). 
Individuals in the cohort are followed from their entry into study until they die, 
withdraw from the investigation while still alive or reach the time of end of the investigation, 
whichever of these three events occurs first. These last two situations are examples of right 
censoring, which plays an important role in estimating survival rates. 
In the next presentation of the Kaplan-Meier method (Klugman, Panjer and Willmot, 
2008) lifetimes will be considered as a function of time 𝑡,without mention of a starting age 𝑥. 
Suppose the population under study is composed of N individuals, in the presence of 
non-informative censoring, and d deaths are observed. Then, 𝑁 − 𝑑 lives are censored. Let: 
• 𝑡1 < 𝑡2 <  … <  𝑡𝑘  , 𝑘 ≤ 𝑑, be the ordered times at which deaths are observed. 
Define 𝑡0 = 0 ; 
• 𝑑𝑗 denote the number of deaths at time 𝑡𝑗 (𝑗 = 1,… , 𝑘) , with 𝑑𝑗 ≥ 1 ( 𝑑 = ∑ 𝑑𝑠
𝑘
𝑠=1 ); 
• 𝑟𝑗, known as the risk set, denote the number of individuals alive and uncensored at 
𝑡𝑗
− (𝑗 = 1,… , 𝑘); 
• 𝑐𝑗 denote the number of individuals censored in the interval [𝑡𝑗  , 𝑡𝑗+1[                              
(0 ≤ 𝑗 ≤ 𝑘 − 1). 
 
 Therefore, 𝑟1 = 𝑁 − 𝑐0 and 𝑟𝑗 = 𝑁 − ∑ 𝑑𝑠
𝑗−1
𝑠=1 − ∑ 𝑐𝑠
𝑗−1
𝑠=0   , 2 ≤ 𝑗 ≤ 𝑘.  
                                                          ⇒ 𝑟𝑗 = 𝑟𝑗−1 − 𝑑𝑗−1 − 𝑐𝑗−1 , 2 ≤ 𝑗 ≤ 𝑘. 
 It can be shown that the Kaplan-Meier estimate, ?̂?(𝑡), is a monotonically non-
increasing step function and is obtained by multiplying the survival probabilities, 
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑠𝑢𝑟𝑣𝑖𝑣𝑜𝑟𝑠 𝑎𝑡 𝑡𝑗
𝑟𝑖𝑠𝑘 𝑠𝑒𝑡 𝑎𝑡 𝑡𝑗





                                                                   1 ,                        𝑡 <  𝑡1 





   ,    𝑡𝑗−1 ≤ 𝑡 < 𝑡𝑗                          (8) 





    𝑜𝑟  0     , 𝑡 > 𝑡𝑘  
 
3.2.2 Estimation of expected survival 
The expected survival function is estimated to provide a comparison between the survival of 
the population of elite athletes and the standard population. The most common approaches 
are the exact method, the cohort method and the conditional expected survival. These three 
methods differ in how long the athlete’s counterpart in the standard population is considered 
to be at risk for the calculation of the expected survival. 
The exact method, also known as Ederer I method (Ederer, Axtell and Cutler, 
1961), assumes a complete follow-up for all athletes; consequently, the matched individuals 
are considered to be at risk indefinitely. There is a technical problem with this method, since 
it often requires standard population data that is not yet available, namely, for the younger 
individuals under study. 
 The conditional expected survival, known as Ederer II method (Ederer and Heise, 
1959), is based on the actual follow-up time, therefore, matched individuals are considered 
to be at risk only until the corresponding athletes die or are censored. 
 The cohort method, proposed by Hakulinen (Hakulinen, 1982), takes into account 
potential follow-up time, which is the maximum possible time that an individual can be 
followed-up from the date of entry into study to the last potential time of observation. 
Explicitly, if the study subject is censored, the matched referent is assumed to be no longer 
at risk (actual follow-up), but if he dies, the counterpart is considered to remain at risk 
(maximum potential follow-up).  
In the following (Pokhrel, 2007; Therneau and Offord, 1999), brief formulae for the 
estimation of expected survival by each method is given, applying, for simplicity, the 
convention that both the begin date and the end of follow-up occurred on an individual’s 
birthday. Again, lifetimes will be considered as a function of time 𝑡 (𝑡 ≥ 0).  
Let 𝒑𝒊𝒌
𝒔  be the annual conditional expected survival probability of a corresponding 
person in the standard population similar to the 𝑖𝑡ℎ athlete, with respect to age and calendar 
year of entry into study. The expected probabilities for individual 𝑖, obtained from the 






Interval Age Calendar year 𝑝𝑖𝑘
𝑠  
[0,1[ a y 𝑝𝑖1
𝑠  
[1, 2[ a+1 y+1 𝑝𝑖2
𝑠  
… … … … 
Table 3.3 – Illustration of age and calendar year specific annual survival probabilities. 
The expected probability of individual 𝑖 surviving until the end of interval [𝑡 − 1, 𝑡[ 






                                                                (9) 
Exact method 
The cumulative expected survival probability from beginning of study to the end of interval 
[𝑡 − 1, 𝑡[ is estimated by: 

















 ,                                   (10) 
 
where 𝑙1 is the number of individuals at risk at the start of the first interval (which is 
equivalent to 𝑁, defined in section 3.2.1). Therefore, the estimate by the exact method is an 
average of the cumulative expected survival probabilities of all individuals who enter into 
study. 
 
Conditional expected survival 
The first step in Ederer II method consists in calculating the annual survival probabilities for 









       (𝑘 = 1,2,… ),                                                 (11) 
where 𝑙𝑘 is the number of individuals at risk (alive and not censored) at the start of interval 
[𝑘 − 1, 𝑘[. The next and final step is obtaining the estimate of the survival function at time 𝑡: 

















The cohort method for the estimation of the expected survival function was initially proposed 






After specifying the potential follow-up times for all individuals, let consider a 
generic interval [𝑘 − 1, 𝑘[. From the group of individuals with potential follow-up greater or 
equal to 𝑘 − 1, define two subgroups: 𝛼𝑘 having a potential follow-up greater or equal to 𝑘 
and 𝛽𝑘 having a potential follow-up less than 𝑘. The latter are, in effect, those who withdraw 
during the interval. An expected life table can be built considering: 
- the expected number of individuals alive and under observation at time 𝑘 − 1: 
𝑙𝑘
∗ = {




   , 𝑖𝑓 𝑘 ≥ 2                                          (13) 







 ∑[1 − 𝑝𝑖𝑘
𝑠 ]
𝑖∈𝛼𝑘
                   , 𝑖𝑓 𝑘 = 1
∑ 𝑆𝑖
𝑠(𝑘 − 1) × [1 − 𝑝𝑖𝑘
𝑠 ]  , 𝑖𝑓 𝑘 ≥ 2
𝑖∈𝛼𝑘
                                (14) 










                   , 𝑖𝑓 𝑘 = 1 
∑ 𝑆𝑖
𝑠(𝑘 − 1) × √𝑝𝑖𝑘
𝑠
𝑖∈𝛽𝑘
  , 𝑖𝑓 𝑘 ≥ 2 
                                   (15) 










                      , 𝑖𝑓 𝑘 = 1
∑ 𝑆𝑖
𝑠(𝑘 − 1) × [1 − √𝑝𝑖𝑘
𝑠 ]
𝑖∈𝛽𝑘
  , 𝑖𝑓 𝑘 ≥ 2
                                   (16)  




∗                                                       (17) 
  
Then, the expected interval-specific survival probability is estimated using the 
actuarial (life table) approach: 
𝑝∗








                                                       (18) 
 Finally, the expected cumulative survival from the beginning of the first interval to 
the end of interval [𝑡 − 1, 𝑡[ by the Hakulinen method, is given by: 










3.3 Years of Life Lost/Saved 
 
Most of the studies included in literature review use indirect standardisation of elite athletes’ 
mortality to assess the difference in mortality between two populations or, otherwise, to 
conclude that there is no statistically significant difference between them. As already 
mentioned, the clear majority found a greater survival of elite athletes when compared to the 
general population. While this is a useful approach in mortality comparison and a valuable 
way to give a background to new research, it may not be straightforward to interpret. For 
example, a 30% lower mortality is better than a 20% lower mortality, but what does a 10% 
difference mean in terms of life duration? 
A possible tool to provide a time dimension measure for athletes’ longevity is 
determining the number of years of life lost (YLL) in case of shorter longevity than the 
standard population, or saved, otherwise. The years lost method, as proposed by Andersen 
(2013), quantifies the expected number of years of life lost due to a given cause of death 
before a certain age. It has been primary developed to be applied in studies of cancer patients.  
In sports, the overall years lost/saved is obtained as a stand-alone measure of 
mortality. In addition, it is often determined for each major cause of death, as well as 
according to the main type of physiological effort, allowing comparisons between groups 
(Antero-Jacquemin J, 2018). 
The determination of YLL (Andersen, 2013) requires the definition of the following 
measures. 
- Life expectancy at time 0: 𝑒0 = ∫ 𝑝0𝑡
∞
0
𝑑𝑡                                                              (20) 
- Temporary life expectancy, also known as restricted mean life time, between 𝑡 = 0 
and 𝑡 = 𝑥:     𝑒0𝑥 = ∫ 𝑝0𝑡
𝑥
0
𝑑𝑡                                                                                           (21) 
 
The life expectancy at time 0, 𝑒0, corresponds to the area under the survival curve, 
while 𝑒0𝑥  is the area under the curve until the given threshold 𝑡 = 𝑥. 
Noticing that the equation 𝑝0𝑡 + 𝑞0𝑡 = 1 holds, and integrating it from 𝑡 = 0 to  
𝑡 = 𝑥, another balance equation is obtained: 
𝑒0𝑥 + ∫ 𝑞0𝑡
𝑥
0











Rearranging equation (22), 𝑌𝐿𝐿(0, 𝑥) is obtained by subtracting temporary life 
expectancy from 𝑥: 
𝑌𝐿𝐿(0, 𝑥)  = 𝑥 − 𝑒0𝑥                                                       (23) 
  
Graphically, it corresponds to the area above the survival curve, 𝑦 = 𝑆(𝑡), and below 
the horizontal line at 1, 𝑦 = 1, from 𝑡 = 0 to 𝑡 = 𝑥. Equivalently, this is the area under the 
lifetime distribution function 𝐹(𝑡), until 𝑡 = 𝑥. 
Finally, the years of life lost method can be used to compare life expectancies between 
two populations. Temporary life expectancy can be expressed as a function of the total 
number of years and the number of years lost. For example, for country 𝑐1: 
𝑒0𝑥




𝑑𝑡 ,                                                     (24) 
and then the difference between the life expectancies of two populations can be obtained by 
looking at their years lost as: 
𝑒0𝑥
𝑐1 − 𝑒0𝑥















𝑐2  , the total number of years lost before 𝑥 is larger in population 𝑐2 than 
in 𝑐1. Under the context of this work, denoting 𝑐1 as the group under study and 𝑐2 as the 
standard population, if the difference in (25) is positive it represents the survival gain, in 
terms of years saved, of the group of athletes in comparison to the standard population. 
Otherwise, a negative result in (25) estimates the number of years lost in the group of athletes 
in relation to the standard population.  
The same methodology can be applied when estimating the years saved/lost from a 
certain cause of death, following the competing risk model (Andersen, 2013), through the 
replacement of the overall probabilities of dying by the cumulative incidence functions for a 
specific cause. 
Notice that all the quantities presented can be defined conditionally on survival until 
time 𝑡 = 𝑥. For instance, the temporary life expectancy between times 𝑥 and 𝑥 + 𝑛 is:          
𝑒𝑥𝑛 = ∫ 𝑝𝑡 𝑥
𝑛
0









3.4 Cox Proportional Hazard Models 
 
In addition to comparing the mortality of elite athletes with that of a standard 
population, it is also interesting to analyse if there are mortality differences inside the group 
of athletes, resulting from having different characteristics. For example, it can be investigated 
if mortality of a team player (football, baseball, etc.) is influenced by his/her position on the 
field.  
Cox Proportion Hazard Model (Cox, 1972) is applicable in this context, besides being 
one of the most widely used tools of survival analysis. The quantity that plays a central role 






𝑃(𝑇 ≤ 𝑡 + ℎ | 𝑇 > 𝑡)  ,                                         (26) 
where 𝑇 is the random variable representing the future lifetime at time 0. The hazard rate is 
an instantaneous measure of mortality at time 𝑡 and fully describes the lifetime distribution 
(as the survival distribution does). If the time scale is age, the hazard rate is usually 
represented as 𝜆(𝑥) and 𝑇 is the future lifetime at birth. 
In the Cox Proportional Hazard Model, the hazard rate takes the form: 
𝜆(𝑡, 𝒛) =  𝜆0(𝑡)𝑒
𝜷𝒛𝑇  ,                                                         (27) 
where 𝒛 is a vector of covariates, which are the different factors used to split the population 
under study into homogeneous subgroups; 𝜷 is a vector of regression parameters and 𝜆0(𝑡) 
is the baseline hazard (all 𝒛𝒊 = 0), a function of time 𝑡 and independent of the covariates. 
This is a semi-parametric model since the baseline hazard is unspecified, that is, no 
assumptions are made about the shape of  𝜆0(𝑡) before analysing the data. 
Noticing that the hazards of different individuals with covariate vectors 𝒛𝟏 and 𝒛𝟐 are 







= 𝑐𝑜𝑛𝑠𝑡𝑎𝑛𝑡  ,                                                (28) 
Cox regression belongs to the category of proportional hazard models.  
Since the aim of the analysis is to compare mortality across different groups, 𝜆0(𝑡) 
can be “ignored”. Then, the vector 𝜷 is estimated from the data, through the maximisation of 
the partial likelihood function and assuming a method (e.g. Breslow’s approximation) to 
handle deaths that occur at the same time. For more details, cf. IFOA (Subject CT4, 2011). 
The Cox Proportional Hazard Model is fitted in software R with the coxph function, 






In the literature, there are several works that have used the Cox Proportional Hazard 
technique to analyse the effect of specific variables in mortality of athletes, as already 
mentioned in Chapter 2. Here, it should be emphasised that most of them use the age attained 
by the athlete at entry into study as the relevant time scale, allowing for censored observations 
(Zwiers et al., 2012; Baron et al., 2012; Koning et al., 2014). Alternatively, follow-up time 
can be chosen, though being an approach primarily used in epidemiological studies. 
The covariates used vary from study to study, depending on the characteristics of the 
sport, the data availability and the main objective of the research. While Koning et al. (2014) 
focused on overall mortality of NFL players, examining whether observable factors as 
number of games played, position played and race, influence the individual risk of mortality, 
Baron et al. (2012) studied the association of NFL players position category and BMI with 
cardiovascular disease mortality. Targeting a broader group of elite athletes, those who 
participated in the Olympic Games between 1896 and 1936, Zwiers et al. (2012) determined 
hazard ratios for all-cause mortality dependent on different levels of exercise intensity, risk 
of bodily collision and levels of physical contact. 
Besides mortality, Cox Proportional Hazard Models were also used to assess 
disability relative risks. One example is the study based on a cohort of male Finnish elite 
athletes (Sarna et al., 1997) evaluating the association between the type of sport – endurance 
athletes, team games and power sports – with specific disabilities. 
The models are usually adjusted for other variables, as race, era of play, time since 
last game played and calendar year of follow-up (by decades) in Baron et al. (2012); sex, year 












Chapter 4 – Applications 
 
The methodologies presented in Chapter 3 will now be applied to populations of elite athletes, 
to evaluate whether they live longer than the corresponding general population. 
It was possible to collect data from two populations of professional football players, 
who have represented at least once their National Team, namely, the players of the 
Portuguese Football Team and the players of the Spanish Football Team. 
The overall mortality of players was compared with that of the general population of 
their respective countries, using the Human Mortality Database (http://www.mortality.org/).  
 For all data in this collection and throughout the study, age and time are arranged in 
1, 5, and 10-year intervals. In the computations, available death rates, exposure-to-risk and 
life tables are used in the six configurations available in the Human Mortality Database 
(HMD): 1x1, 1x5, 1x10, 5x1, 5x5, and 5x10, with the first number always referring to the 
age interval and the second number to the time interval. For example, 1x5 denotes a 
configuration with single years of age and 5-year time intervals. Furthermore, the intervals 
are inclusive, both for age and time, in the sense that the age-group 20-24 extends from exact 
age 20 up to, but not including, exact age 25, as well as the time period designated by 1970-
1974 begins at 1 January 1970 and ends at 31 December 1974. Following the convention in 
the HMD, the first year of life (age 0) is always separated from the rest of its age group (ages 
1-4), and the last age category is for ages 110 and above. 
In HMD, data is available in periods – period data, i.e., by year of occurrence – and 
in cohorts – cohort data, i.e., by year of birth. The statistics are typically collected, published 
and tabulated in period life tables; hence, this format is preferentially used.  
 Moreover, in the standardisation process, the central mortality rates (𝑚𝑗  in this study 
notation) are widely used, which are referred as death rates in HMD.  For period life tables, 
the values of 𝑚𝑗 below age 80 are by definition equal to the observed population death rates. 
At older ages, the number of deaths and the exposure-to-risk eventually become quite small, 
leading to considerable random variation in observed death rates. In order to obtain an 
improved representation of the underlying mortality, death rates for ages greater or equal than 
80 are smoothed by fitting a logistic function, before being converted to probabilities of death 
in HMD. For cohort data, this adjustment is not performed.  
 Regarding statistical analysis, p-values lower than 0.05 were considered to 
indicate statistical significance and the 95% confidence intervals were calculated using 





4.1 Mortality of Portuguese Football Players 
 
4.1.1 Data collection and statistical analysis 
Data on Portuguese football players who have represented the national team, for the 1921-
2015 period, was collected from the official website of the Portuguese Football Federation 
(http://www.fpf.pt), from a very complete Portuguese website with worldwide statistics of 
football (http://www.zerozero.pt/) and complemented with other sources (https://eu-
football.info/, http://www.national-football-teams.com/). The most difficult information to 
obtain was the date of death, which sometimes was found by a deep search in the football 
team’s websites, sports news and memorials.  
 A total of 589 Portuguese football players have represented at least once the national 
team in either World Cup, European Championships or even friendly games. From this group, 
59 football players were excluded owing to unknown date of birth, date of death, or both. 
Among the remaining 530 footballers, 133 were known to have died by 31 December 2015.  
 The follow-up for each player was defined by the difference between the date of 
endpoint (31 December 2015 if alive; otherwise, the date of death) and the date of his first 
match representing the Portuguese football team. The date of the end of the study was the 
only censoring point. Whenever the year of death was the only information, it was assumed 
that the player died at the middle of that year. The age of death ranged from 23 to 99 years 
old, with a mean of 67.98 (± 15.63). 
 Information about the number of games played by the national team and the total 
number of games in their careers was collected. Players were also placed into one of four 
positional categories: goalkeeper, defender, midfielder and forward.  
 Table 4.1 lists summary statistics for the players followed during the 1921-2015 
period, which corresponds to years of birth between 1894 and 1997.  
The overall mortality of players was compared with that of the Portuguese male 
population, using the Human Mortality Database. 
Notice that period life tables for Portugal are available from 1940 until 2015 and 











Total number of players 530 
     Alive at 31 December 2015 397 (75%) 
     Dead at 31 December 2015 133 (25%) 
Age at the first representation (mean±SD) 23.86 (± 3.10) 
Age at the end of the study, for the players still alive 52.47 (± 18.25) 
Age at death (mean±SD) 67.98 (± 15.63) 
Number of games played by the national team (mean±SD) 14.89 (± 20.82) 
Number of games played in the entire football career (mean±SD) 309.10 (± 151.87) 
Goalkeepers 47 
Defenders 163 
Midfielders  169 
Forwards 151 
Table 4.1 - Characteristics of Portuguese Football Players (1921-2015 period). 
Sources: FPF; Zerozero.pt; national-football-teams and eu-football.info 
 
4.1.2 Results 
As a first approach, overall mortality of the Portuguese football players was compared with 
the Portuguese male population through the computation of standardised mortality ratios, 
along with 95% confidence intervals by the exact method.  
 The computations were performed with the data standardised in the six different 
settings of age and time-intervals defined before.  The results showed to be very similar; for 
instance, the SMR ranged from 0.6217 in a 5x10 setting to 0.6448 in a 1x5 setting. To 
maintain a uniform format, from now onwards, the interpretations will be based on the results 
reached with a 5x1 configuration, that is, 5-year age classes and 1-year intervals. The other 
results are presented in the Appendix.  
An overall standardised mortality ratio of 0.6236 suggests a substantially and 
significantly lower mortality of Portuguese football players compared with the general 
Portuguese male population (p < 0.05). The corresponding 95% confidence interval is 
[0.5221; 0.7390], that is, if the study was repeated many times using samples from the same 
population, the true SMR would be expected to fall within that interval in 95% of the times 
(Klugman et al., 2008). 
Overall mortality according to the players’ positions was observed to be lower 
than that of the general population for all four categories (SMR<1), although marginally 






SMR 95% CI for SMR p-value 
Overall 0.6236 0.5221 – 0.7390 0.0000 
    Goalkeepers 0.5582 0.3124 – 0.9206 0.0188 
    Defenders 0.5696 0.3921 – 0.7999 0.0005 
    Midfielders 0.7186 0.4976 – 1.0041 0.0532 
    Forwards 0.6285 0.4680 – 0.8263 0.0004 
Table 4.2 –SMR for Portuguese football players, 95% CI and p-value: overall and stratified by position 
 
  
Categorising deaths in 10-year age classes, SMR obtained are all lower than 1, which 
reveals consistency across age (Figure 4.1). For instance, the SMR for the 60-69 age class is 
0.6037 (95% CI: 0.3868 – 0.8983; p =0.01), meaning that it was observed an actual number 
of deaths 39.63% lower than the expected. However, the SMR of the 50-59 and 70-79 age 













Figure 4.1– SMR for Portuguese football players by 10-year age class and respective 95% CI 
  
 
The period effect was evaluated using two complementary approaches. First, deaths 
that occurred within each of the calendar periods 1921-1952, 1953-1973, 1974-1994, 1995-
2015, were considered and the respective SMR and 95% CI estimated (Table 4.3). A lower 
mortality of players, when compared with the general male population, was observed across 
the periods, except the first one, 1921 – 1952, in whom a non-significant SMR of 1.29 was 
obtained. Among the nine deceased players in this period, three causes of death are known, 






















SMR 95% CI p-value 
1921-1952 9 6.97 1.29 0.59 – 2.45 0.53 
1953-1973 13 22.19 0.59 0.31 – 1.00 0.05 
1974-1994 49 64.34 0.76 0.56 – 1.01 0.06 
1995-2015 62 119.78 0.52 0.40 – 0.66 0.00 
Table 4.3– Standardised mortality ratio over time (four periods) for Portuguese football players 
 
 In the second method to account for mortality trends over time, the same calendar 
periods were considered, with the difference being the allocation of the players according to 
the date of the first match played in the national team. Among the players who have 
represented Portugal for the first time between 1921 and 1952, 88 have already died by 31 
December 2015. In this scenario, the standardisation process estimates that 124.54 individuals 
die until the end of the investigation, yielding a SMR of 0.7066 (CI: 0.5667-0.8706).  Of the 
121 and 163 footballers who played for the first time in the 1953–1973 and 1974–1994 
periods, respectively, 38 and 7 had died by 31 December 2015, yielding SMRs of 0.5640 (CI: 
0.3991-0.7741) and 0.3588 (CI: 0.1443-0.7393). All estimated SMR were statistically 
significant (p<0.05). Since only the youngest are considered in the last period, 1995-2015, no 
death was recorded in this group.  
For simplicity, in the estimation of Kaplan-Meier observed survival function of 
Portuguese football players, follow-up was defined as: age at exit from study - age at entry 
into study. The estimation of expected survival was performed using the three methods 
presented in section 3.2.2, considering 1-year intervals from 𝑡 = 0 to 𝑡 = 77 (last follow-up).  
Hakulinen and Ederer II curves are very similar, and the last one was chosen to be illustrated 







   
 
 





The observed curve is generally above the expected curve, shifting to the right early 
in the follow-up period and widening the gap until the end of follow-up. The difference 
between the curves is statistically significant. This strengthens the conclusion of greater 
survival of Portuguese football players when compared to the standard population. 
Besides, observed and expected survival probability is also estimated considering age 
in 𝑥-axis, instead of follow-up time. Following Andersen (2013), the determination of life 
years saved/lost is based on the lifetime distribution function 𝐹𝑥(𝑡) = 𝑞𝑡 𝑥 = 1 − 𝑆𝑥(𝑡), 
which represents the probability that a life aged 𝑥 dies before attaining age 𝑥 + 𝑡. The area 
below the observed distribution function (at each age) estimates the average number of life 
years lost from the time of first representation of National Team until the age of 99. Likewise, 
the average number of years lost by the counterparts of the athletes in the general population 
is calculated by the area under the expected distribution function. Then, the lower risk of 
death of the Portuguese football players is estimated by the difference between the two areas. 
Numerically, the players cohort saved on average 5.73 years of life in relation to the general 
population, until the final age point of 99 years-old. 
Notice that the result would be the same using survival distributions – the number of 
years saved would continue to be estimated by the area between the two curves. In this case, 
the area under each curve would be interpreted as the temporary life expectancy. 
Cox Proportional Hazard Models were used to evaluate the association between 
player position on the field, and total number of games, with overall mortality. Several models 
were developed using different time scales and adjustment for confounders (age at first match, 
year of birth and/or period of participation). Models using follow up as the time scale are 
included in the Appendix. The results in this section were obtained considering age as the 
time scale, with players entering the analysis at the age of first representation of the National 
Team (left-truncation) and exiting at their death/censoring age. Consequently, every model 
was adjusted for age.  
In Table 4.4 are summarized the results for number of games in the entire career, 
which are treated as a categorical variable after application of decision trees. Model G.1 is 
only adjusted for age, while model G.2 is additionally adjusted for calendar period of 
participation (allocation by year of first representation). The category of number of games 
≤134 and the calendar period 1921–1952 were chosen to be kept in the baseline, since are 








Table 4.4 – Cox proportional hazard ratios and 95% CI for number of games (model G.1 – adjusted for age; 
model G.2 – adjusted for age and period of participation) for Portuguese football players. 
 
Table 4.5 displays the results for player position, with Model P.1 being adjusted for 
age and Model P.2 being adjusted for age and calendar period of participation. Likewise, 
1921–1952 period is kept in the baseline, as well as forwards, which were chosen as the 
reference group due to the higher observed death rate. 
 
Table 4.5 – Cox proportional hazard ratios and 95% CI for position on the field (model P.1 – adjusted for 
age; model P.2 – adjusted for age and period of participation) for Portuguese football players. 
 
Table 4.6 includes multivariate models for number of games and player position 
analysed simultaneously. 
 
Table 4.6 – Cox proportional hazard ratios and 95% CI for multivariate models including number of games 
and position on the field (model GP.1 – adjusted for age; model GP.2 – adjusted for age and period of 
participation) for Portuguese football players 
 Hazard Ratio (95% CI) 
 Model G.1 Model G.2 
N. Games ]134,366] 0.53 (0.36 – 0.78) 0.63 (0.42 – 0.92) 
N. Games > 366 0.82 (0.47 – 1.43) 1.34 (0.74 – 2.44) 
   
PP 1953-1973  0.49 (0.32 – 0.75) 
PP 1974-2015  0.22 (0.09 – 0.53) 
 Hazard Ratio (95% CI) 
 Model P.1 Model P.2 
Defenders 0.84 (0.54 - 1.31) 1.01 (0.64 – 1.58) 
Goalkeepers 0.86 (0.48 - 1.53) 0.90 (0.51 – 1.61) 
Midfielders 1.04 (0.67 - 1.61) 1.27 (0.81 – 1.98) 
   
PP 1953-1973  0.50 (0.33 – 0.75) 
PP 1974-2015  0.24 (0.10 – 0.55) 
 Hazard Ratio (95% CI) 
 Model GP.1 Model GP.2 
N. Games ]134,366] 0.52 (0.35 – 0.77) 0.60 (0.41 – 0.89) 
N. Games > 366 0.80 (0.45 – 1.42) 1.30 (0.71 – 2.37) 
   
Defenders 0.90 (0.58 – 1.41) 1.03 (0.66 – 1.62) 
Goalkeepers 0.93 (0.52 – 1.65) 0.92 (0.52 – 1.65) 
Midfielders 1.16 (0.74 – 1.81) 1.37 (0.87 – 2.16) 
   
PP 1953-1973  0.47 (0.31 – 0.72) 





From all the models it can be concluded that position played is not a significant 
predictor of mortality of Portuguese football players (CI for all models include the value 1).  
Players in specific positions have different physical profiles and anthropometric 
characteristics. For example, the midfielders run the longest distances compared to forwards 
or defenders (Vigne et al., 2010). Defenders have more body fat than forwards and 
midfielders. Forwards are the quickest players in the team. Goalkeepers tend to be the tallest 
and have a better performance on explosive power tests than players in the field (Sporis et 
al., 2009). However, this work suggests that these distinct characteristics, besides others not 
mentioned, are not enough to lead to differences in mortality according to position for 
Portuguese football players. This result contrasts, for instance, with the higher mortality, and 
particularly higher cardiovascular disease rates, of NFL linemen players when compared to 
other positions, mainly due to their higher BMI. Also, isometric training, which is an 
important component of linemen’s training regimen, has been shown to result in significant 
structural remodeling of the heart (Baron et al., 2012). On the other side, football players 
have similar training preparations regardless the position on the field. 
Players with a total number of games between 135 and 366 exhibit decreased 
mortality when compared to players with less than 135 games (baseline), ranging from 37% 
lower mortality in the Cox model for number of games adjusted for age and period of 
participation (model G.2), to 48% lower mortality in the multivariate model having number 
of games and position as covariates and controlling for age (model GP.1). However, players 
with more than 366 games in their career do not verify a survival advantage in relation to 
players with less than 135 games. This result seems to indicate that a longer football career 
is beneficial for longevity up to a certain threshold.  
 
4.2 Mortality of Spanish Football Players 
 
4.2.1 Data collection and statistical analysis 
Data on Spanish football players who have represented their national team, for the 1920-2014 
period, was collected mainly from the Real Federación Española de Fútbol 
(http://www.sefutbol.com/jugadores) and from a very complete website with the required 
statistics (http://www.bdfutbol.com/), being completed with other sources (https://eu-
football.info/, http://www.national-football-teams.com/). 
The procedures applied were the same as for the Portuguese players, with a few 





From the 751 football players who have represented at least once the Spanish national 
team, only 7 were excluded due to unknown date of death. In contrast with the Portuguese 
case, there was more information available. Among the remaining 744 footballers, 275 were 
known to have died by 31 December 2014.  
 The follow-up for each player was defined by the difference between the date of 
endpoint (31 December 2014 if alive; otherwise, the date of death) and the date of his first 
match representing the Spanish football team. Notice that the end of study is 31 December 
2014, one year earlier than the Portuguese date, according to the availability of data in HMD. 
 The summary statistics for the players followed from 1920 to 2014, corresponding to 
years of birth between 1889 and 1995, are listed in Table 4.7.  
Total number of players 744 
     Alive at 31 December 2014 469 (63%) 
     Dead at 31 December 2014 275 (37%) 
Age at the first representation (mean±SD) 23.88 (± 2.85) 
Age at the end of the study, for the players still alive 51.53 (± 16.75) 
Age at death (mean±SD) 69.19 (± 16.10) 
Number of games played by the national team (mean±SD) 12.09 (± 20.15) 
Number of games played in the entire football career (mean±SD) 283.6 (± 152.80) 
Goalkeepers 49 
Defenders 231 
Midfielders  229 
Forwards 235 
Table 4.7 - Characteristics of Spanish Football Players (1920-2014 period). 
Sources: Rfef; Bdfutbol; national-football-teams and eu-football.info 
  
The overall mortality of Spanish players was compared with that of the Spanish male 
population, using the Human Mortality Database.  
 For Spain, there was no need to use cohort data, since period life tables were available 
from 1908 onwards and the national team’s debut was in 1920. 
 
4.2.2 Results 
In a similar way to the previous section, mortality of the Spanish football players was primary 
compared with the Spanish male population through the computation of standardised 





 Likewise, the computations were performed with the data standardised in the six 
different settings of age and time-intervals defined before.  The results showed to be very 
similar, with SMR varying between 0.9399 in a 5x10 setting and 0.9486 in a 1x1 setting. To 
maintain a uniform format, from now onwards, interpretations will be based on the results 
reached with a 5x1 configuration, that is, 5-year age classes and 1-year intervals. The other 
results are presented in the Appendix.  
 An overall SMR of 0.9416 was obtained for the Spanish football players, that is, it is 
estimated that this group of elite athletes have a 5.84% lower mortality than the Spanish 
standard population. However, the verified mortality difference based on SMR is not 
statistically significant at 5%, since the p-value is 0.3327. Indeed, the 95% confidence interval 
for SMR, [0.8336; 1.0597], contains the value 1. Therefore, the hypothesis of similar 
mortality of the Spanish football players with the general population is not rejected.  
 Regarding the position played, the SMR are lower than 1, except for forward players. 
Again, the results are not statistically significant at 5%. Nevertheless, goalkeepers stand out 
with a p-value of 5.79%, meaning that, at 90% confidence level (α=10%), the SMR of 0.6484 
would be significant. 
 
SMR 95% CI for SMR p-value 
Overall 0.9416 0.8336 – 1.0597  0.3327 
    Goalkeepers 0.6484 0.3904 – 1.0125 0.0579 
    Defenders 0.9052 0.7132 – 1.1330 0.4189 
    Midfielders 0.9596 0.7736 – 1.1768 0.7417 
    Forwards 1.0613 0.8512 – 1.3075 0.6055 
Table 4.8 –SMR for Spanish football players, 95% CI and p-value: overall and stratified by position 
 
The SMR by age-class (Figure 4.3) confirm that there is no statistical evidence of 
difference in mortality between players and its standard population (CI including the value 
1). However, notice that the estimated SMR are lower than 1 for younger age-classes and 
greater than 1 for groups above 70 years-old. Once more, some of these results would be 
significant at 90% confidence level. For instance, for the 40–49 age group it is obtained a 







Figure 4.3– SMR for Spanish football players by 10-year age class and respective 95% CI 
  
The period effect was evaluated using two complementary approaches. First, deaths 
that occurred within each of the calendar periods 1920–1935, 1936–1955, 1956–1975, 1976–







SMR 95% CI p-value 
1920-1935 8 6.31 1.2674 0.5472 – 2.4972 0.6000 
1936-1955 13 24.52 0.5302 0.2823 – 0.9066 0.0165 
1956-1975 43 50.76 0.8472 0.6131 – 1.1412 0.3076 
1976-1995 107 97.52 1.0973 0.8992 – 1.3259 0.3613 
1996-2014 104 112.96 0.9207 0.7523 – 1.1156 0.4295 
Table 4.9– Standardised mortality ratio over time (five periods) for Spanish football players 
  
It was only in the 1936–1955 period that the SMR was statistically different from 1, 
being estimated a 46.98% lower mortality of Spanish players. This might be associated with 
the higher death rates of the Spanish general population as a consequence of the Civil War 
(1936–1939), a period of conflict and massive violence. It is even known that many players 
departed the country, mostly from Catalonia and Basque Country, regions facing Francisco 
Franco repression. For instance, in 1937, FC Barcelona undertook a tour of games in America, 
including Mexico and USA, to escape a country in war as well as to raise funds for the club 
(Fútbol Club Barcelona - Official Website). In the same way, Athletic Bilbao, a team allowing 
only Basque-born players, took part in a tour of matches throughout Europe, the Soviet Union 



















lower mortality of Spanish football players in comparison to the general population, since 
they were not affected by the events in terms of mortality. 
In the second approach to account for mortality trends over time, players were 
allocated to a period according to the date of their first representation of the Spanish National 
Team. The first three calendar periods were the same as in the first method, but the last two 
periods were joined, since only one death occurred among the players who first represented 
Spain between 1996 and 2014 and the result would not be meaningful. Apart from the 1920–
1935 period, all SMR were lower than 1, however, statistical evidence does not reject the 
hypothesis of identical mortality between the Spanish football players and the Spanish general 
population for each period. 
 The observed Kaplan-Meier survival curve was estimated, considering follow-up in 
𝑥-axis. The expected survival, based on the Spanish general male population death rates, was 
determined through both Ederer II and Hakulinen methods, giving similar results. To keep 












Figure 4.4 – Spanish football players observed and expected survival curves 
 
In opposition to the Portuguese case, the observed survival curve does not lie entirely 
above the expected survival. It happens at the beginning, but as time increases, the gap 
between the curves progressively narrows, until 𝑡 = 54, when the curves start crossing each 
other. The expected survival is superior at the end of the follow-up (from 𝑡 = 63 onwards). 
The years lost method is applied using the same approach as in the Portuguese case 
study. However, in the Spanish framework, the observed and expected survival curves, 
estimated using age in 𝑥-axis, cross each other. Clearly, the same occurs with the lifetime 





years lost. At the end, Spanish football players saved on average 1.76 years of life in 
comparison to the Spanish general population, until 98 years-old. This value is much lower 
than the one obtained for Portuguese players. 
Cox Proportional Hazard Models were again used to evaluate the association between 
player position on the field, and total number of games, with overall mortality. The results in 
this section were obtained considering age as the time scale, where players enter the analysis 
at the age of first representation of the National Team (left-truncation) and exit at their 
death/censoring age. Therefore, every model is adjusted for age. Models using follow up as 
the time scale were also developed, with adjustments for age at first match and year of birth, 
which are included in the Appendix.  
Table 4.10 shows the results for the number of games in the entire career, which was 
transformed into a categorical variable through the application of decision trees. Model G.3 
is only adjusted for age, while Model G.4 is additionally adjusted for year of birth. Players 
with less than 199 games were chosen as the reference group since they have the higher 
observed death rates. 
 
Table 4.10 – Cox proportional hazard ratios and 95% CI for number of games (model G.3 – adjusted for 
age; model G.4 – adjusted for age and year of birth) for Spanish football players. 
 
Regarding the position on the field, midfielders are kept in the baseline, also due to 
the higher observed death rate. Model P.3 is adjusted for age and Model P.4 is adjusted for 
age and year of birth (Table 4.11). 
 
Table 4.11 – Cox proportional hazard ratios and 95% CI for position on the field (model P.3 – adjusted for 
age; model P.4 – adjusted for age and year of birth) for Spanish football players. 
 Hazard Ratio (95% CI) 
 Model G.3 Model G.4 
N. Games ]198,350] 0.54 (0.41 – 0.70) 0.77 (0.55 – 1.07) 
N. Games > 350 0.33 (0.20 – 0.54) 0.55 (0.31 – 0.96) 
   
Birth Year  0.98 (0.97 – 0.99) 
 Hazard Ratio (95% CI) 
 Model P.3 Model P.4 
Forwards 1.10 (0.82 – 1.47) 1.23 (0.91 – 1.66) 
Defenders 0.89 (0.66 – 1.21) 1.04 (0.77 – 1.42) 
Goalkeepers 0.58 (0.35 – 0.96) 0.65 (0.39 – 1.07) 
   





Table 4.12 includes multivariate models for number of games and player position 
analysed simultaneously. 
 
Table 4.12 – Cox proportional hazard ratios and 95% CI for multivariate models including number of games 
and position on the field (model GP.3 – adjusted for age; model GP.4 – adjusted for age and year of birth) 
for Spanish football players 
 
Results show that the number of games in the career of a Spanish football player 
influences their survival. Hazard ratios adjusted for age indicated a lower mortality for players 
with a greater number of games: 0.54 and 0.53 HR for players with number of games 
belonging to ]198, 350] in, respectively, univariate (G.3) and bivariate (GP.3) models, when 
compared to the baseline; 0.33 HR for number of games > 350 in relation to the baseline 
group, both in univariate and bivariate models (G.3 and GP.3). These lower mortality risks 
remained after adjusting for year of birth, but with less pronounced hazard ratios, whereas the 
hazard ratio for players with number of games belonging to ]198,350] became non-
significant. The observed significant reduction of mortality for players with greater number 
of games in their curriculum underpins the findings of beneficial effects in longevity of 
sustained and strenuous competition. 
Comparing the mortality of forwards, defenders and goalkeepers with midfielders, it 
was not seen, in general, a mortality difference. The only exception was goalkeepers in model 
P.3 (Table 4.11), showing a 42% lower mortality compared to midfielders. However, this 
survival advantage was not reached in any other model, even considering follow up as the 
time scale (see Appendix). This result is in line with the Portuguese study, reinforcing the 
idea that the position on the field is not a determinant factor for mortality of football players. 
 
 
 Hazard Ratio (95% CI) 
 Model GP.3 Model GP.4 
N. Games ]198,350] 0.53 (0.4 – 0.69) 0.75 (0.53 – 1.04) 
N. Games > 350 0.33 (0.2 – 0.54) 0.55 (0.31 – 0.96) 
   
Forwards 1.29 (0.96 – 1.74) 1.29 (0.96 – 1.74) 
Defenders 0.99 (0.73 – 1.34) 1.05 (0.77 – 1.43) 
Goalkeepers 0.69 (0.42 – 1.14) 0.68 (0.41 – 1.13) 
   





4.3 Comparing the mortality of Portuguese and Spanish 
football players 
  
The previous computations of Portuguese and Spanish football players are based on different 
standard populations; therefore, the results (e.g., standardised mortality ratios) are not 
comparable.   
To this end, a common standard population should be chosen to compare the mortality 
of the two populations under study, and then the DSMR and ISMR can be determined. In this 
case, the standardisation process was done only by age (5-year age groups), providing a 
meaningful comparison of the age-specific mortality rates of each population.   
First, it was used the Spanish general population as the standard and, afterwards, the 
population of the Portuguese and Spanish football players were pooled to create a standard 
population. The relevant measures are illustrated in Table 4.13. 
 Standard Population 
 Spanish general population Pooled population 
CMR standard population 0.0111 0.0096 
DSMR Portuguese players 0.0055 0.0080 
DSMR Spanish players 0.0076 0.0108 
ISMR Portuguese players 0.0065 0.0079 
ISMR Spanish players 0.0088 0.0108 
 
Table 4.13 – Single figure measures of mortality (CMR, DSMR and ISMR) for Spanish and Portuguese 
football players based on two different standard populations. 
In both approaches, the DSMR as well as the ISMR are greater for the Spanish cohort 
of football players than for the Portuguese cohort. The ratio of DSMR of the Portuguese to 
the Spanish cohort is 0.7199 and 0.7371 in first and second approaches; while the ratio of 
ISMR is 0.7353 and 0.7336, respectively. Consequently, the single figure measures show a 
higher mortality for the Spanish football players compared to the Portuguese football players, 
after adjusting for age. 
This latter difference as well as the results concerning the SMR required further 
clarification and motivated the comparison of the life expectancy at birth between the Spanish 





For the 1940–2014 period, it was found that the life expectancy at birth is higher for 
the Spanish population in relation to the Portuguese population for every year (apart from 
1940 and 1941), as illustrated in Figure 4.5. 
Figure 4.5 – Life expectancy at birth for Portuguese and Spanish general population (1940-2014). 
 
Thus, the survival advantage of the Portuguese football players in comparison to the 
Spanish football players, combined with the lifespan advantage of the Spanish general 
population is a possible reason for the significant lower mortality of the Portuguese football 
players in comparison to its standard population, a phenomenon not observed for the Spanish 
players. Nevertheless, further investigation is needed to justify the differences. 





Chapter 5 – Conclusion 
 
In the context of recent concerns regarding potential negative health effects of high-level 
physical exercise, research on the mortality of elite athletes is of particular interest. A 
comprehensive literature review was undertaken, with the vast majority of the studies 
concluding that top-level athletes live longer than the general population, even if a few 
indicated that these mortality differences are not significant.   
Trying to provide a meaningful contribution to the topic, a search on Portuguese elite 
athletes (for which no mortality study was found) was performed. However, only information 
on football players was available. Actually, collecting the data was notably the most time-
consuming stage, including the compilation of the information in a data base. It was then 
possible to analyse mortality of Portuguese football players who have already represented the 
National Team at least once in their professional career, during the period from 1921 to 2015. 
In order to have a more complete study, the Spanish Football players’ mortality was also 
investigated for the 1920-2014 period. 
 This study shows that playing football at an elite level does not increase overall 
mortality or shorten lifespan. 
For Spanish football players, it was not observed a mortality difference compared 
with the Spanish reference population. However, it should be highlighted that there was a 
significant reduction in the mortality ratio for the 1936-1955 period. Although speculative, 
this may be correlated to the Spanish Civil War, as already elucidated. 
The results were more significant in the case of Portuguese football players, with an 
average of 5.73 years of life saved and a 37.64% overall lower mortality when compared to 
the general Portuguese population. This reduction in overall mortality was consistent across 
age-groups, time periods (except for deaths allocated to the 1921-1952 period) and position 
on the field. The difference between the observed and the expected survival curves since the 
beginning of follow-up illustrated the football players’ survival advantage over the general 
population.  
The findings on Portuguese football players are in line with the study of Taioli (2007), 
who estimated a significant 32% lower mortality for football players enrolled in the Italian A 
and B professional leagues between 1975 and 2003. 
There was not found a significant difference in mortality according to the position the 
players occupy in the field, both for the Portuguese and Spanish cohorts. On the contrary, it 





mortality. Usually, these athletes are the fittest and also less frequently injured, reinforcing 
the contributions to longevity of a high physical level. 
The cohorts of Portuguese and Spanish football players were also compared through 
direct and indirect standardisation methods and a clear gap in mortality discriminates both 
populations, with a survival advantage for Portuguese athletes. Even though genetic 
background, social and environmental factors may differ, it seems likely that the 
characteristics of such athletes are broadly comparable across these nationalities. Therefore, 
further research is needed to clarify the difference. For example, data on the lifestyle habits 
after their professional career would have been informative to study the impact on mortality. 
The higher expectancy at birth of the Spanish general population in relation to the 
Portuguese population, combined with the aforementioned survival advantage of the group 
of Portuguese football players justify, partially, the findings in this study: a significant lower 
mortality of Portuguese players contrasting with no mortality difference of Spanish players 
in comparison to their respective standard population.  
Although this essay provided a main contribution to the field by a complete mortality 
overview of the Portuguese and Spanish football players, it has its limitations. Firstly, it was 
not possible to validate the dates of death via official national sources. Secondly, it was 
necessary to exclude football players for whom the date of death is unknown, especially in 
the case of Portugal, accounting for 10% of the population under study. However, these 
deaths correspond mainly (97%) to individuals whose first game representing the National 
Team occurred before 1953, and the SMR analysed separately for the periods of participation 
1953-1973, 1974-1994 and 1995-2015 were significantly smaller than one, confirming the 
substantial reduction in overall mortality. 
Besides analysing overall mortality of elite athletes, studying the specific causes of 
death allow a better understanding of the long-term risks and benefits on their longevity. For 
instance, Marijon et al. (2013) estimated a 41% lower mortality for Tour de France French 
cyclists, for which contributed a significant reduction in mortality for neoplasms, 
cardiovascular diseases, respiratory system diseases and digestive system diseases. 
Nevertheless, according to the study of Lehman et al. (2012), despite the lower overall 
mortality of retired NFL players, they have a higher neurodegenerative mortality. Even 
similar overall mortality between elite athletes and the reference population comprised 
reduced mortality for cancer and an increased mortality due to external causes in power 
Finnish athletes (Sarna et al., 1993). Unfortunately, mortality by cause of death was not 
available for most Portuguese and Spanish football players, making it impossible to develop 





Analysing mortality of football players from other countries could provide insight to 
the results obtained in this work. Future research could also focus on assessing mortality of 
different sports, as well as including women elite athletes, since there is a current paucity of 
studies assessing their longevity. Again, available data is necessary to perform this 
investigation. 
A possible field of further research could be the development of insurance products 
specifically designed to elite athletes. Analysing their mortality and morbidity risks 
accurately is therefore crucial in this area. 
As a final comment, following the opinion of Sanchis-Gomar et al. (2011), 
“physicians, health professionals and general population should not hold the impression that 
strenuous exercise and/or high level aerobic competitive sports have deleterious effects, are 
bad for one’s health, and shorten life”. However, it should be noted that the elite level of 
physical activity is not a plausible and reasonable goal for most people. Hence, the final 
general recommendation should be to practice exercise regularly, ideally prescribed and 
supervised by a professional in the area – “Even a little is good; a lot is better if you are well 

















A. Hypothesis test for the standardised mortality ratio 
Besides estimating the SMR, one question of interest is its statistical significance. The test 
statistic is derived from the usual assumption that, under the null hypothesis (H0: SMR=1), 
the number of deaths, denoted by the random variable 𝐷, follows a Poisson distribution with 
mean equal to the expected number of deaths, Ê = ∑ 𝐸𝑗 𝑚𝑗
𝑠𝑀
𝑗=1 . It is assumed that Ê is based 
on a sufficiently large sample, so that it can be taken as a constant (Breslow and Day, 1987). 
Defining d as the observed number of deaths and noticing that it is a two-side test, the 
exact p-value is calculated in the following way: 
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 Byar (Breslow and Day, 1987) suggested an extremely accurate approximation to the 
exact Poisson test, based on the asymptotic Normal Distribution of the test-statistic: 








] ~ 𝑁(0,1)      ,                                (31) 
 
where 𝐷’ = 𝑑 + 1  if  𝑑 < Ê  and 𝐷’ = 𝑑 if 𝑑 > Ê , in the observed value of 𝑇. 
 Consequently, the approximate p-value is obtained by: 
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B. Confidence Interval for the standardised mortality ratio 
A statistical question of interest is the determination of a (1-α) confidence interval for the true 
value of SMR, where α is the selected significance level. If the study were to be repeated 
many times, using the same method to select different samples from the population, the true 
SMR would be expected to fall within the interval estimates in (1-α) % of the cases. 
 In practice, the exact confidence interval for the SMR is determined by first finding 







 . Based on Liddell (1984), the lower and upper limits satisfy, respectively, 
the following equations: 








 These are quite simple to solve considering the relationship between the Poisson and 
𝜒2 distributions (Fisher, 1935): the sum of the terms of the Poisson series with parameter 𝜇 
up to but excluding the term 𝑐 is equal to the survival probability of a 𝜒2 distribution with 2𝑐 
degrees of freedom evaluated at the value 2𝜇. More formally: 
 𝑃(𝐷 < 𝑐) = 𝑃(𝜒(2𝑐)
2 > 2𝜇) (36) 
Rearranging relationship (36), two more expressions are obtained: 
 𝑃(𝐷 ≥ 𝑐) = 1 − 𝑃(𝜒(2𝑐)
2 > 2𝜇) (37) 
 𝑃(𝐷 ≤ 𝑐) = 𝑃(𝜒(2𝑐+2)
2 > 2𝜇) (38) 
 
 Consequently, the upper and lower limits are found as follows: 
Lower limit: find 𝜇𝐿 such that 𝑃(𝜒(2𝑑)
2 > 2𝜇𝐿) = 1 −
𝛼
2
                                      (39) 
Upper limit: find 𝜇𝑈 such that 𝑃(𝜒(2𝑑+2)
2 > 2𝜇𝑈) =
𝛼
2
                                         (40) 
 Alternatively, for large 𝑑, an approximate method can be used, based on the 
standardised normal test statistic (31) suggested by Byar (Breslow and Day, 1987). For a (1-
α) confidence interval, the approximate limits for the mean are:  
 























 As an illustration, consider that 𝑑 = 51 deaths occurred in a population while 
Ê=81.15 would have been expected applying the mortality rates of some standard population, 
which yields a SMR of 0.6285. The 95% confidence interval requires α=0.05.  
 Applying the exact procedure, for the lower and upper limits, the degrees of freedom 
of the  𝜒2 distribution are, respectively, 102 and 104. The critical values in (39) and (40) are 
found using a calculator: 2𝜇𝐿 = 75.9457 ⇒ 𝜇𝐿 = 37.97285 and 2𝜇𝑈 = 134.1112 
⇒  𝜇𝑈 = 67.05558 . Consequently, SMR𝐿 =
37.97285
81.15




0.8263. That is, the 95% confidence interval for the standardised mortality ratio is [0.4679; 
0.8263]. 




C. SMR and 95% CI for every setting of age/time-periods 
Configuration 





SMR 95% CI p-value 
1x1 133 212.91 0.6247 0.523 - 0.7403 0.000 
5x1 133 213.28 0.6236 0.5221 - 0.739 0.000 
1x5 132 204.70 0.6448 0.5395 - 0.7647 0.000 
5x5 132 205.56 0.6421 0.5373 - 0.7615 0.000 
1x10 133 213.22 0.6238 0.5223 - 0.7392 0.000 
5x10 132 213.93 0.6217 0.5205 - 0.7368 0.000 
Table C.1 – SMR, 95% CI and p-value for Portuguese football players 
 
Configuration 





SMR 95% CI p-value 
1x1 275 289.92 0.9486 0.8397 – 1.0675 0.3987 
5x1 275 292.06 0.9416 0.8336 – 1.0597 0.3327 
1x5 275 290.12 0.9479 0.8392 – 1.0668 0.3922 
5x5 275 292.25 0.9410 0.8330 – 1.0590 0.3273 
1x10 275 290.52 0.9466 0.8380 – 1.0653 0.3794 
5x10 276 292.58 0.9399 0.8321 – 1.0578 0.3180 





D. Cox Proportional Hazard Models 
 
Table D.1 – Cox proportional hazard ratios and 95% CI, using follow up as time scale, for Portuguese 
football players (model 1 – HR for number of games, adjusted for period of participation; model 2 – HR 
for position on the field, adjusted for period of participation; model 3 – HR for number of games and 




Table D.2 – Cox proportional hazard ratios and 95% CI, using follow up as time scale, for Spanish football 
players (model 1 – HR for number of games, adjusted for age at first match and year of birth; model 2 – 
HR for position on the field, adjusted for age at first match and year of birth; model 3 – HR for number of 





 Hazard Ratio (95% CI) 
 Model 1 Model 2 Model 3 
N. Games ]134,366] 0.64 (0.44 – 0.95)  0.61 (0.41 – 0.91) 
N. Games > 366 1.16 (0.64 – 2.11)  1.11 (0.61 – 2.02) 
Defenders  1.04 (0.66 – 1.64) 1.06 (0.68 – 1.67) 
Goalkeepers  1.03 (0.58 – 1.83) 1.02 (0.57 – 1.81) 
Midfielders  1.35 (0.86 – 2.10) 1.45 (0.92 – 2.28) 
PP 1953–1973 0.54 (0.36 – 0.83) 0.54 (0.36 – 0.82) 0.52 (0.34 – 0.80) 
PP 1974–2015 0.25 (0.10 – 0.61) 0.26 (0.11 – 0.61) 0.24 (0.10 – 0.57) 
 Hazard Ratio (95% CI) 
 Model 1 Model 2 Model 3 
N. Games ]198,350] 0.78 (0.56 – 1.1)  0.75 (0.53 – 1.05) 
N. Games > 350 0.56 (0.32 – 0.98)  0.55 (0.31 – 0.97) 
    
Forwards  1.21 (0.9 – 1.63) 1.28 (0.94 – 1.72) 
Defenders  1.04 (0.76 – 1.43) 1.05 (0.77 – 1.43) 
Goalkeepers  0.67 (0.41 – 1.12) 0.70 (0.42 – 1.17) 
    
Age at first match 1.07 (1.03 – 1.11) 1.07 (1.03 – 1.12) 1.08 (1.03 – 1.12) 
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Lin Y, Gajewski A and Poznańska A (2016). Examining mortality risk and rate of ageing 
among Polish Olympic athletes: a survival follow-up from 1924 to 2012, British Medical 






Mann HB and Whitney DR (1947). On a test of whether one of two random variables is 
stochastically larger than the other, The Annals of Mathematical Statistics, 18, 50–9. 
 
Marijon E, Tafflet M, Antero-Jacquemin J, El Helou N, Berthelot G, Celermajer DS, 
Bougouin W, Combes N, Hermine O, Empana J-P, Rey G and Toussaint J-F (2013). Mortality 
of French participants in the Tour de France (1947–2012), European Heart Journal, 34, 
3145–150. 
 
McKee AC, Cantu RC, Nowinski CJ, Hedley-Whyte ET, Gavett BE, Budson AE, Santini VE, 
Lee H, Kubilus CA and Stern RA (2009). Chronic traumatic encephalopathy in athletes: 
progressive tauopathy following repetitive head injury, Journal of Neuropathology and 
Experimental Neurology, 68(7), 709–35. 
 
Pärssinen M, Kujala U, Vartiainen E, Sarna S and Seppälä T (2000). Increased premature 
mortality of competitive powerlifters suspected to have used anabolic agents, International 
Journal of Sports Medicine, 21, 225–27. 
 
Pelliccia A, Kinoshita N, Pisicchio C, Quattrini F, Dipaolo FM, Ciardo R, Di Giacinto B, 
Guerra E, De Blasiis E, Casasco M, Culasso F and Maron BJ (2010). Long-Term Clinical 
Consequences of Intense, Uninterrupted Endurance Training in Olympic Athletes, Journal of 
the American College of Cardiology, 55, 1619–625. 
 
Pokhrel A (2007), – Age-Standardization of Relative Survival Ratios, academic dissertation, 
University of Tampere, Finnish Cancer Registry. 
 
Reynolds R and Day S (2012). Life Expectancy and Comparative Mortality of Major League 
Baseball players, 1900–1999. WebmedCentral SPORTS MEDICINE, 3(5): WMC003380. 
 
Ribeiro CS (2014), Econometria, Lisboa, Escolar Editora. 
 
Sanchis-Gomar F, Olaso-Gonzalez G, Corella D, Gomez-Cabrera MC and Vina J (2011). 
Increased Average Longevity among the “Tour de France” Cyclists, International Journal of 






Sarna S, Kaprio J, Kujala UM and Koskenvuo M (1997). Health status of former elite athletes. 
The Finnish experience, Aging Clinical and Experimental Research, 9, 35–41. 
 
Sarna S, Sahi T, Koskenvuo M and Kaprio J (1993). Increased life expectancy of world class 
male athletes, Medicine and Science in Sports and Exercise, 25, 2, 237-44. 
 
Schnohr P (1971). Longevity and causes of death in male athletic champions, Lancet, 298 
(7738), 1364-366. 
 
Sporis G, Jukic I, Ostojic SM and Milanovic D (2009). Fitness profiling in soccer: physical 
and physiologic characteristics of elite players, Journal of Strength and Conditioning 
Research, 23, 1947–953. 
 
Taioli E (2007). All causes mortality in male professional soccer players, European Journal 
of Public Health, 17(6), 600–04. 
 
Therneau T and Offord J (1999), – Expected Survival Based on Hazard Rates, Technical 
Report No. 63, Section of Biostatistics, Mayo Clinic. 
 
Vigne G, Gaudino C, Rogowski I, Alloatti G and Hautier C (2010). Activity Profile in Elite 
Italian Soccer Team, International Journal of Sports Medicine, 31(5), 304–10. 
 
Wooldridge JF (2012). Introductory Econometrics - A Modern Approach, 3rd ed., South-
Western, Cengage Learning. 
 
World Health Organization (2010), Global Recommendations on Physical Activity for 
Health, Switzerland: WHO Press. 
 
Zwiers R, Zantvoord FW, Engelaer FM, van Bodegom D, van der Ouderaa FJG, Westendorp 
GJ (2012). Mortality in former Olympic athletes: retrospective cohort analysis, British 











Data from First Division (Liga BBVA), Second Division (Liga Adelante), Second B and 
Spain National Team. Available at: https://www.bdfutbol.com/ . Last accessed: August 2018. 
 
European National Football Teams matches database. Available at: https://eu-football.info/ . 
Last accessed: August 2018. 
 
Federação Portuguesa de Futebol. Available at: https://www.fpf.pt/Jogadores . Last accessed: 
August 2018. 
 
National Football Teams. Available at: https://www.national-football-teams.com/ . Last 
accessed: August 2018. 
 
Real Federación Española de Fútbol. Available at: http://www.sefutbol.com/jugadores . Last 
accessed: August 2018. 
 
Shkolnikov, V., Barbieri, M. and Wilmoth, J. (2018). Human Mortality Database. Available 
at: https://www.mortality.org/ . Last accessed: August 2018. 
 
Zerozero.pt. Available at: https://www.zerozero.pt/jogadores.php . Last accessed: August 
2018. 
 
 
 
 
 
 
 
 
 
